3.5 Arzneiformen

Publikationen

1.

Screening for the anti-inflammation quality markers of Xiaojin Pills based on HPLC-MS/MS method, COX-2 inhibition test and protein interaction network.

Sci Rep. 2018 May;8(1):7454.
PMID: 29748583 [PubMed - as supplied by publisher]

2.

A novel lecithin based delivery form of Boswellic acids (Casperome®) for the management of osteo-muscular pain: a registry study in young rugby players.

Eur Rev Med Pharmacol Sci. 2016 10;20(19):4156-4161.
PMID: 27775780 [PubMed - indexed for MEDLINE]

3.

A single-dose, randomized, cross-over, two-way, open-label study for comparing the absorption of boswellic acids and its lecithin formulation.

Phytomedicine. 2016 Nov;23(12):1375-1382.
PMID: 27765357 [PubMed - indexed for MEDLINE]

4.

Improved efficacy of cisplatin in combination with a nano-formulation of pentacyclic triterpenediol.

Mater Sci Eng C Mater Biol Appl. 2016 Nov;68():109-116.
PMID: 27524002 [PubMed - indexed for MEDLINE]

5.

Nanoparticle formulation of 11-keto-β-boswellic acid (KBA): anti-inflammatory activity and in vivo pharmacokinetics.

Pharm Biol. 2016 Dec;54(12):2909-2916.
PMID: 27305832 [PubMed - as supplied by publisher]

6.

Survey on the Quality of the Top-Selling European and American Botanical Dietary Supplements Containing Boswellic Acids.

Planta Med. 2016 Apr;82(6):573-9.
PMID: 27054914 [PubMed - indexed for MEDLINE]

7.

Carbon Dioxide Expanded Ethanol Extraction: Solubility and Extraction Kinetics of α-Pinene and cis-Verbenol.

Anal Chem. 2016 Apr;88(8):4336-45.
PMID: 27002237 [PubMed - as supplied by publisher]

8.

Development and optimization of boswellic acid-loaded proniosomal gel.

Drug Deliv. 2016 Oct;23(8):3072-3081.
PMID: 26953869 [PubMed - indexed for MEDLINE]

9.

Extraction and Characterization of Boswellia Serrata Gum as Pharmaceutical Excipient.

Polim Med. 2015 Jan-Jun;45(1):25-30.
PMID: 26630726 [PubMed - indexed for MEDLINE]

10.

Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir.

J Pharm Pharmacol. 2016 May;68(5):678-91.
PMID: 26454138 [PubMed - indexed for MEDLINE]

11.

Combination of Anti-Diabetic Drug Metformin and Boswellic Acid Nanoparticles: A Novel Strategy for Pancreatic Cancer Therapy.

J Biomed Nanotechnol. 2015 Jan;11(1):93-104.
PMID: 26301303 [PubMed - indexed for MEDLINE]

12.

Enhanced Neuroprotection of Acetyl-11-Keto-β-Boswellic Acid (AKBA)-Loaded O-Carboxymethyl Chitosan Nanoparticles Through Antioxidant and Anti-Inflammatory Pathways.

Mol Neurobiol. 2016 08;53(6):3842-3853.
PMID: 26162321 [PubMed - indexed for MEDLINE]

13.

Comparative studies of pharmacokinetics and anticoagulatory effect in rats after oral administration of Frankincense and its processed products.

J Ethnopharmacol. 2015 Aug;172():118-23.
PMID: 26117531 [PubMed - indexed for MEDLINE]

14.

Gastroretentive Matrix Tablets of Boswellia Oleogum Resin: Preparation, Optimization, In Vitro Evaluation, and Cytoprotective Effect on Indomethacin-Induced Gastric Ulcer in Rabbits.

AAPS PharmSciTech. 2016 Apr;17(2):328-38.
PMID: 26092303 [PubMed - indexed for MEDLINE]

15.

Boswellia carterii liquisolid systems with promoted anti-inflammatory activity.

Curr Drug Deliv. 2015;12(4):454-63.
PMID: 25895614 [PubMed - indexed for MEDLINE]

16.

Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.

J Pharm Pharmacol. 2015 Sep;67(9):1188-97.
PMID: 25851251 [PubMed - indexed for MEDLINE]

17.

Boswellia gum resin/chitosan polymer composites: Controlled delivery vehicles for aceclofenac.

Int J Biol Macromol. 2015;77():303-6.
PMID: 25825076 [PubMed - indexed for MEDLINE]

18.

Prospects of boswellic acids as potential pharmaceutics.

Planta Med. 2015 Mar;81(4):259-71.
PMID: 25714728 [PubMed - indexed for MEDLINE]

19.

A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis.

Clin Cosmet Investig Dermatol. 2014;7():321-7.
PMID: 25419153 [PubMed - as supplied by publisher]

20.

Transdermal microemulsions of Boswellia carterii Bird: formulation, characterization and in vivo evaluation of anti-inflammatory activity.

Drug Deliv. 2015;22(6):748-56.
PMID: 24725029 [PubMed - indexed for MEDLINE]

21.

Investigating permeability related hurdles in oral delivery of 11-keto-β-boswellic acid.

Int J Pharm. 2014 Apr;464(1-2):104-10.
PMID: 24463070 [PubMed - indexed for MEDLINE]

22.

Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract.

Drug Dev Ind Pharm. 2015 Mar;41(3):382-97.
PMID: 24329130 [PubMed - indexed for MEDLINE]

23.

Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil.

Int J Nanomedicine. 2012;7():2033-43.
PMID: 22619540 [PubMed - indexed for MEDLINE]

24.

Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent.

Agents Actions. 1986 Jun;18(3-4):407-12.
PMID: 3751752 [PubMed - indexed for MEDLINE]